logo-loader

Avacta CEO Dr Alastair Smith 'encouraged' by first commercial Affimer deal

Published: 19:46 25 Apr 2017 AEST

Dr Alastair Smith, chief executive of Avacta Group Plc (LON:AVCT) tells Proactive they're at an “important value inflection point” after validating the commercial potential of its Affimer technology.

It follows the successful evaluation of its technology by a “large, global diagnostics developer”.

This has led the partner company to acquire the exclusive rights to several Affimer reagents for an undisclosed sum.

Australian Strategic Materials signs US$600 million LoI

Rowena Smith, CEO and managing director of Australian Strategic Materials Ltd (ASX:ASM, OTC:ASMMF), joins Jonathan Jackson in the Proactive studio to discuss the company’ s Dubbo Project, in Central West New South Wales. This project aims to extract and process critical minerals and rare earth...

4 hours, 44 minutes ago